{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:06:53Z","timestamp":1792624013733,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":2749,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1111\/jth.12916","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T02:24:09Z","timestamp":1427595849000},"page":"909-919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management"],"prefix":"10.1016","volume":"13","author":[{"given":"A.","family":"Casini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Neerman-Arbez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Ari\u00ebns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"de Moerloose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12916_bb0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0033-1349222","article-title":"Congenital fibrinogen disorders: an update","volume":"39","author":"de Moerloose","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12916_bb0015","first-page":"380","article-title":"Congenital hypofibrinogenemia with fibrinoasthenia","volume":"13","author":"Imperato","year":"1958","journal-title":"Helv Paediatr Acta"},{"key":"10.1111\/jth.12916_bb0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/218134a0","article-title":"Fibrinogen Detroit \u2013 a molecular defect in the N-terminal disulphide knot of human fibrinogen?","volume":"218","author":"Blomback","year":"1968","journal-title":"Nature"},{"key":"10.1111\/jth.12916_bb0025","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0030","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2012-09-306639","article-title":"Mechanisms of fibrin polymerization and clinical implications","volume":"121","author":"Weisel","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2141.1983.tb07309.x","article-title":"A new type of congenital dysfibrinogenaemia with defective fibrin lysis \u2013 Dusard syndrome: possible relation to thrombosis","volume":"53","author":"Soria","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12916_bb0040","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/j.1538-7836.2006.02043.x","article-title":"A classification of the fibrin network structures formed from the hereditary dysfibrinogens","volume":"4","author":"Sugo","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0045","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1538-7836.2011.04424.x","article-title":"Fibrinogen replacement therapy for congenital fibrinogen deficiency","volume":"9","author":"Bornikova","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0050","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/j.thromres.2010.09.004","article-title":"Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia","volume":"126","author":"Miesbach","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12916_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0038-1653741","article-title":"Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen","volume":"73","author":"Haverkate","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2014-06-582866","article-title":"Natural history of patients with congenital dysfibrinogenemia","volume":"125","author":"Casini","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1160\/TH05-11-0749","article-title":"Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation","volume":"96","author":"Brennan","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0070","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/j.1538-7836.2006.02240.x","article-title":"A Bbeta 14 Arg\u00a0\u2013>\u00a0Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain\u00a0III)","volume":"4","author":"de Raucourt","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1160\/TH08-09-0559","article-title":"Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: fibrinogen Mannheim\u00a0V","volume":"102","author":"Dempfle","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5858\/2002-126-0499-LDOD","article-title":"Laboratory diagnosis of dysfibrinogenemia","volume":"126","author":"Cunningham","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/jth.12916_bb0085","series-title":"Index of Variant Human Fibrinogens","author":"Ebert","year":"1994"},{"key":"10.1111\/jth.12916_bb0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bjh.12085","article-title":"Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia","volume":"160","author":"Shapiro","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12916_bb0095","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0049-3848(94)90287-9","article-title":"Screening of dysfibrinogenaemia using the fibrinogen function versus antigen concentration ratio","volume":"76","author":"Krammer","year":"1994","journal-title":"Thromb Res"},{"issue":"Suppl. 2","key":"10.1111\/jth.12916_bb0100","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(13)70004-5","article-title":"Epidemiology and treatment of congenital fibrinogen deficiency","volume":"130","author":"Peyvandi","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12916_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.thromres.2004.05.008","article-title":"Diagnostic utility of comparing fibrinogen Clauss and prothrombin time derived method","volume":"114","author":"Llamas","year":"2004","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12916_bb0110","first-page":"12","article-title":"Fibrinogen kaiserslautern\u00a0III: a new case of congenital dysfibrinogenemia with aalpha 16 arg\u2013>cys substitution","volume":"31","author":"Loreth","year":"2001","journal-title":"Haemostasis"},{"key":"10.1111\/jth.12916_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1096-8652(200003)63:3<149::AID-AJH8>3.0.CO;2-#","article-title":"Fibrinogen Longmont: a dysfibrinogenemia that causes prolonged clot-based test results only when using an optical detection method","volume":"63","author":"Lefkowitz","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.12916_bb0120","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/pbc.24383","article-title":"Use of purified fibrinogen concentrate for dysfibrinogenemia and importance of laboratory fibrinogen activity measurement","volume":"60","author":"Franzblau","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/jth.12916_bb0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1600-0609.1986.tb00829.x","article-title":"Increased binding to ADP-stimulated platelets and aggregation effect of the dysfibrinogen Oslo\u00a0I as compared with normal fibrinogen","volume":"36","author":"Thorsen","year":"1986","journal-title":"Scand J Haematol"},{"issue":"Suppl. 1","key":"10.1111\/jth.12916_bb0130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jth.12229","article-title":"Fibrin(ogen) and thrombotic disease","volume":"11","author":"Ariens","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0135","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.thromres.2014.03.026","article-title":"Thromboelastographic phenotypes of fibrinogen and its variants: clinical and non-clinical implications","volume":"133","author":"Galanakis","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12916_bb0140","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MBC.0b013e32830ef90c","article-title":"Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency","volume":"19","author":"Kalina","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0145","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1160\/TH13-08-0657","article-title":"Benign FGB (148Lys\u2013>Asn, and 448Arg\u2013>Lys), and novel causative gamma211Tyr\u2013>His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia","volume":"111","author":"Brennan","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0150","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1182\/blood.V96.10.3473","article-title":"Fibrinogen Ales: a homozygous case of dysfibrinogenemia (gamma-Asp(330)\u2013>Val) characterized by a defective fibrin polymerization site \u2018a\u2019","volume":"96","author":"Lounes","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0155","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1182\/blood.V87.11.4686.bloodjournal87114686","article-title":"A gamma Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki\u00a0I","volume":"87","author":"Niwa","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ajh.23162","article-title":"Fibrinogen Sumperk\u00a0II: dysfibrinogenemia in an individual with two coding mutations","volume":"87","author":"Kotlin","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.12916_bb0165","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1160\/TH13-05-0408","article-title":"Partial deletion of the alphaC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis","volume":"110","author":"Westbury","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0170","doi-asserted-by":"crossref","first-page":"33129","DOI":"10.1016\/S0021-9258(20)30106-X","article-title":"A frameshift mutation in exon\u00a0V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano\u00a0III","volume":"269","author":"Furlan","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12916_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MBC.0b013e32834cb243","article-title":"Heterozygous Bbeta-chain C-terminal 12 amino acid elongation variant, BbetaX462W (Kyoto\u00a0VI), showed dysfibrinogenemia","volume":"23","author":"Okumura","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0038-1651583","article-title":"Paris\u00a0I dysfibrinogenemia: a point mutation in intron\u00a08 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain","volume":"69","author":"Rosenberg","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0185","series-title":"Williams Hematology","first-page":"1","article-title":"Hereditary fibrinogen abnormalities","author":"Neerman-Arbez","year":"2010"},{"key":"10.1111\/jth.12916_bb0190","doi-asserted-by":"crossref","first-page":"17778","DOI":"10.1074\/jbc.M001618200","article-title":"Recombinant fibrinogen\u00a0Vlissingen\/Frankfurt\u00a0IV. The deletion of residues\u00a0319 and 320 from the gamma chain of fibrinogen alters calcium binding, fibrin polymerization, cross-linking, and platelet aggregation","volume":"275","author":"Hogan","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12916_bb0195","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V80.8.1972.1972","article-title":"Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461\u2013610 (Lys\u00a0461 AAA\u2013>stop TAA)","volume":"80","author":"Koopman","year":"1992","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0200","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1160\/TH11-10-0731","article-title":"Fibrinogen residue gammaAla341 is necessary for calcium binding and \u2018A-a\u2019 interactions","volume":"107","author":"Park","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0205","series-title":"Hemostasis and Thrombosis: Basic Principles and Clinical Practice","first-page":"693","article-title":"Afibrinogenemias and dysfibrinogenemias","author":"Galanakis","year":"2012"},{"key":"10.1111\/jth.12916_bb0210","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2516.2008.01795.x","article-title":"Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias","volume":"14","author":"Hill","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12916_bb0215","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2141.1983.tb07310.x","article-title":"Delayed release of an abnormal fibrinopeptide\u00a0A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide","volume":"53","author":"Lane","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12916_bb0220","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/MBC.0b013e3282f10157","article-title":"Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide\u00a0A than fibrinopeptide\u00a0B release","volume":"18","author":"Galanakis","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI114154","article-title":"Fibrinogen Stony Brook, a heterozygous A alpha 16Arg\u2014Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly","volume":"84","author":"Galanakis","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12916_bb0230","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2141.2006.06129.x","article-title":"The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance","volume":"134","author":"Flood","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12916_bb0235","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ajh.2830250414","article-title":"Fibrinogen giessen\u00a0I: a congenital homozygously expressed dysfibrinogenemia with A alpha 16 Arg\u2014His substitution","volume":"25","author":"Alving","year":"1987","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.12916_bb0240","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1182\/blood.V69.4.1073.1073","article-title":"Studies on the ultrastructure of fibrin lacking fibrinopeptide\u00a0B (beta-fibrin)","volume":"69","author":"Mosesson","year":"1987","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0245","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V92.7.2195","article-title":"gamma-Chain dysfibrinogenemias: molecular structure\u2013function relationships of naturally occurring mutations in the gamma chain of human fibrinogen","volume":"92","author":"Cote","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0250","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1172\/JCI118091","article-title":"The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo\u00a0II (gamma 275 Arg\u2013>Cys)","volume":"96","author":"Mosesson","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12916_bb0255","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1538-7836.2004.00600.x","article-title":"Recombinant fibrinogen, gamma275Arg\u2013>Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions","volume":"2","author":"Ishikawa","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0260","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1538-7836.2004.00844.x","article-title":"Comparison of thrombin-catalyzed fibrin polymerization and factor\u00a0XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma\u00a0275C, gamma\u00a0275H, and gamma\u00a0275A","volume":"2","author":"Hirota-Kawadobora","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0265","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1160\/TH03-04-0201","article-title":"Fibrinogen Otsu\u00a0I: a gammaAsn319, Asp320 deletion dysfibrinogen identified in an asymptomatic pregnant woman","volume":"90","author":"Terasawa","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0049-3848(01)00273-0","article-title":"Fibrinogen naples\u00a0I (B beta A68T) nonsubstrate thrombin-binding capacities","volume":"103","author":"Meh","year":"2001","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12916_bb0275","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V82.8.2462.2462","article-title":"Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure","volume":"82","author":"Collet","year":"1993","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0280","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1055\/s-0037-1613585","article-title":"New molecular defects in the gamma subdomain of fibrinogen D-domain in four cases of (hypo)dysfibrinogenemia: fibrinogen variants Hannover\u00a0VI, Homburg\u00a0VII, Stuttgart and Suhl","volume":"89","author":"Meyer","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0285","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/MBC.0b013e3282f544ee","article-title":"A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis","volume":"19","author":"Robert-Ebadi","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0290","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.thromres.2014.07.021","article-title":"Two novel mutations in the fibrinogen gamma nodule","volume":"134","author":"Kotlin","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12916_bb0295","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1160\/TH09-07-0432","article-title":"Why dysfibrinogenaemias still matter","volume":"102","author":"Weisel","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2001.tb03495.x","article-title":"A database for human fibrinogen variants","volume":"936","author":"Hanss","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/jth.12916_bb0305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MBC.0b013e328331e6db","article-title":"Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects","volume":"21","author":"Miesbach","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0310","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mbc.0000224841.48463.be","article-title":"Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group","volume":"17","author":"Santacroce","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0315","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MBC.0b013e3283393c7c","article-title":"Severe bleeding in a woman heterozygous for the fibrinogen gammaR275C mutation","volume":"21","author":"Rein","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0320","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1182\/blood.V71.3.613.613","article-title":"Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg\u2014His) containing heterodimeric molecules","volume":"71","author":"Siebenlist","year":"1988","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0325","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.5858\/2002-126-1387-DAT","article-title":"Dysfibrinogenemia and thrombosis","volume":"126","author":"Hayes","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/jth.12916_bb0330","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MBC.0000000000000045","article-title":"Fibrinogen Dusart presenting as recurrent thromboses in the hepatic portal system","volume":"25","author":"Shen","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0335","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1182\/blood.V96.3.1191","article-title":"Familial thrombophilia associated with fibrinogen paris\u00a0V: Dusart syndrome","volume":"96","author":"Tarumi","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0340","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/00365513.2013.826818","article-title":"Dusart syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age","volume":"73","author":"Ramanathan","year":"2013","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/jth.12916_bb0345","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood.V62.2.439.439","article-title":"Hereditary dysfibrinogenemia in a patient with thrombotic disease","volume":"62","author":"Carrell","year":"1983","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0350","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(03)13135-2","article-title":"Genetic regulation of fibrin structure and function: complex gene\u2013environment interactions may modulate vascular risk","volume":"361","author":"Lim","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/jth.12916_bb0355","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/j.thromres.2010.04.011","article-title":"Coexisting dysfibrinogenemia (gamma Arg275His) and FV Leiden associated with thrombosis (Fibrinogen Crete)","volume":"126","author":"Travlou","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12916_bb0360","first-page":"293","article-title":"Coexisting dysfibrinogenemia (gammaR275C) and factor\u00a0V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids)","volume":"11","author":"Siebenlist","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0365","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood-2009-03-208264","article-title":"High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension","volume":"114","author":"Morris","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0370","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2516.2004.00944.x","article-title":"The rare coagulation disorders \u2013 review with guidelines for management from the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"10","author":"Bolton-Maggs","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12916_bb0375","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12916_bb0380","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.siny.2011.07.006","article-title":"Management of pregnancy and delivery in women with inherited bleeding disorders","volume":"16","author":"Peyvandi","year":"2011","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1111\/jth.12916_bb0385","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1517\/14712598.8.7.979","article-title":"Treatment of congenital fibrinogen disorders","volume":"8","author":"de Moerloose","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"Suppl. 2","key":"10.1111\/jth.12916_bb0390","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0049-3848(09)70159-8","article-title":"Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?","volume":"124","author":"Bevan","year":"2009","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12916_bb0395","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.hoc.2011.01.007","article-title":"Factor deficiencies in pregnancy","volume":"25","author":"Pike","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/jth.12916_bb0400","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0002-9440(10)64923-1","article-title":"Fibrinogen stabilizes placental\u2013maternal attachment during embryonic development in the mouse","volume":"160","author":"Iwaki","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1111\/jth.12916_bb0405","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.thromres.2013.08.023","article-title":"The role of fibrin matrices and tissue factor in early-term trophoblast proliferation and spreading","volume":"132","author":"Snir","year":"2013","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12916_bb0410","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MBC.0b013e328322b429","article-title":"Comparisons of the fibrin networks during pregnancy, nonpregnancy and pregnancy during dysfibrinogenaemia using the scanning electron microscope","volume":"20","author":"Pretorius","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0415","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MBC.0b013e32832aec2b","article-title":"Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy","volume":"20","author":"Miesbach","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0420","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0015-0282(02)04694-0","article-title":"Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study","volume":"79","author":"Wang","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1111\/jth.12916_bb0425","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1034\/j.1600-0412.2003.00211.x","article-title":"Dysfibrinogenemia during pregnancy treated successfully with fibrinogen","volume":"82","author":"Yamanaka","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/jth.12916_bb0430","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00277-007-0307-5","article-title":"Management of inherited dysfibrinogenemia during pregnancy: a description of four consecutive cases","volume":"86","author":"Franchini","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1111\/jth.12916_bb0435","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.mbc.0000061286.28953.65","article-title":"Fibrinogen Poissy\u00a0II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide\u00a0B release","volume":"14","author":"Mathonnet","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0440","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.thromres.2010.11.003","article-title":"Congenital dysfibrinogenemia Aalpha Gly13Glu associated with bleeding during pregnancy","volume":"127","author":"Kotlin","year":"2011","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12916_bb0445","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1054\/ijoa.2000.0717","article-title":"Spinal anaesthesia and dysfibrinogenaemia","volume":"10","author":"Meldrum","year":"2001","journal-title":"Int J Obstet Anesth"},{"key":"10.1111\/jth.12916_bb0450","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1172\/JCI116371","article-title":"Molecular basis for fibrinogen Dusart (A alpha 554 Arg\u2013>Cys) and its association with abnormal fibrin polymerization and thrombophilia","volume":"91","author":"Koopman","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12916_bb0455","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1182\/blood.V84.11.3709.bloodjournal84113709","article-title":"A correlation between thrombotic disease and a specific fibrinogen abnormality (A alpha 554 Arg\u2013>Cys) in two unrelated kindred, Dusart and Chapel Hill\u00a0III","volume":"84","author":"Wada","year":"1994","journal-title":"Blood"},{"key":"10.1111\/jth.12916_bb0460","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-0037-1614006","article-title":"Fibrinogen Caracas\u00a0V, an abnormal fibrinogen with an Aalpha 532 Ser\u2013>Cys substitution associated with thrombosis","volume":"84","author":"Marchi","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0465","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1073\/pnas.89.8.3478","article-title":"Abnormal fibrinogens IJmuiden (B beta Arg14\u2014Cys) and Nijmegen (B beta Arg44\u2014Cys) form disulfide-linked fibrinogen\u2013albumin complexes","volume":"89","author":"Koopman","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.12916_bb0470","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1055\/s-0038-1665438","article-title":"Electrospray ionisation mass spectrometry facilitates detection of fibrinogen (Bbeta 14 Arg \u2013> Cys) mutation in a family with thrombosis","volume":"78","author":"Brennan","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0475","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00001721-199910000-00001","article-title":"Fibrinogen Bbeta14 Arg\u2013>Cys: further evidence for a role in thrombosis","volume":"10","author":"Vakalopoulou","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12916_bb0480","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1538-7836.2005.01139.x","article-title":"Bbeta 14 Arg\u00a0\u2013>\u00a0Cys variant dysfibrinogen and its association with thrombosis","volume":"3","author":"Castaman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0485","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1016\/S0021-9258(18)89277-8","article-title":"Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of B beta(9\u201372) corresponding exactly to exon\u00a02 of the gene","volume":"260","author":"Liu","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12916_bb0490","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0038-1647646","article-title":"Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA","volume":"60","author":"Engesser","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12916_bb0495","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1172\/JCI115841","article-title":"Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala\u2014Thr","volume":"90","author":"Koopman","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12916_bb0500","first-page":"575","article-title":"Association of dysfibrinogenemia and thrombosis. Apropos of a family (Fibrinogen Melun) and review of the literature","volume":"146","author":"Bentolila","year":"1995","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1111\/jth.12916_bb0505","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2516.2009.01984.x","article-title":"Pregnancy and rare bleeding disorders","volume":"15","author":"Kadir","year":"2009","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12916","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12916","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622127868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622127868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12916\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:11:22Z","timestamp":1761534682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622127868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1538783622127868"],"URL":"https:\/\/doi.org\/10.1111\/jth.12916","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}